OncoPrecision
About:
Unique Treatments for Unique Patients
Website: https://www.oncoprecision.bio/
Twitter/X: OncoPrecision1
Top Investors: IndieBio, SOSV, AIR Capital, Creative Ventures, GRID EXPONENTIAL
Description:
Leveraging single cell high-throughput biology and AI/ML to dramatically increase the success of cancer therapy.
Total Funding Amount:
$4.16M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
New York, New York, United States
Founded Date:
2020-09-25
Contact Email:
info(AT)oncoprecision.bio
Founders:
Tarek Ali Zaki
Number of Employees:
11-50
Last Funding Date:
2024-06-20
IPO Status:
Private
Industries:
© 2025 bioDAO.ai